Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 μg and 35 μg estrogen preparations

Contraception

Volumn 60, Issue 6, 1999, Pages 321-329

  Rosenberg, Michael J ^a,b   Meyers, Andrea ^a   Roy, Vikki ^a  

^a Health Decisions Inc   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acceptability; Cycle control; Oral contraceptives; Side effects

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ACNE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MASTALGIA; MENSTRUAL CYCLE; NAUSEA; ORAL CONTRACEPTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

AMERICAS; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE USAGE; DEVELOPED COUNTRIES; FAMILY PLANNING; METHOD ACCEPTABILITY; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES, LOW-DOSE--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; RESEARCH METHODOLOGY; RESEARCH REPORT; UNITED STATES; USE-EFFECTIVENESS;

ADOLESCENT; ADULT; BREAST; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HORMONES; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NAUSEA; NORGESTREL; PREGNANCY; STATISTICS, NONPARAMETRIC; UTERINE HEMORRHAGE;

EID: 0033510240     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00109-2     Document Type: Article

References (26)

1. Chasan-Taber L., Stampfer M.J. Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med. 128:1998;467-477.
2. Rosenberg L., Palmer J.R., Sands M.I., et al. Modern oral contraceptives and cardiovascular disease. Am J Obstet Gynecol. 177:1997;707-715.
3. Rosenberg M.J., Waugh M.S., Meehan T.E. Use and misuse of oral contraceptives Risk indicators for poor pill-taking and discontinuation . Contraception. 51:1995;283-288.
4. Rosenberg M.J., Waugh M.S. Oral contraceptive discontinuation A prospective evaluation of frequency and reasons . Am J Obstet Gynecol. 179:1988;577-582.
5. Rosenberg M.J., Burnhill M.S., Waugh M.A., Grimes D.A., Hillard P.J.A. Compliance and oral contraceptives A review . Contraception. 52:1995;137-140.
6. Rosenberg M.J., Waugh M.S. Compliance, counseling, and method satisfaction with oral contraceptives A prospective evaluation . Fam Plann Perspect. 30:1998;89-92.
7. Rosenberg M.J., Waugh M.S., Long S.C. Unplanned pregnancies due to oral contraceptive use, misuse, and discontinuation. J Reprod Med. 40:1995;355-360.
8. Thorneycraft I. Cycle control with oral contraceptives A review of the literature . Am J Obstet Gynecol. 180:1999;S280-S287.
9. Rosenberg M.J., Long S.C. Oral contraceptives and cycle control A critical review of the literature . Adv Contraception. 8:(suppl 1):1992;35-45.
10. Schilling L.H., Bolding O.T., Chenault C.B., et al. Evaluation of the clinical performance of three triphasic oral contraceptives A multicenter, randomized comparative trial . Am J Obstet Gynecol. 160:1989;1264-1268.
11. Droegmueller W., Katta L.R., Bright T.G., Bowes W.A. Triphasic randomized clinical trial Comparative frequency of intermenstrual bleeding . Am J Obstet Gynecol. 161:1989;1407-1411.
12. Rosenberg M.J., Waugh M.S., Stevens C.M. Smoking and cycle control among oral contraceptive users. Am J Obstet Gynecol. 24:1996;628-632.
13. Baron J.A., La Vecchia C., Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 162:1990;502-514.
14. Akerlund M., Rode A., Westergaard. Comparative profiles of reliability, cycle control, and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiol. Br J Obstet Gynaecol. 100:1993;S32-S38.
15. Endrikat J., Muller U., Dusterberg B. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene with respect to efficacy, cycle control, and tolerance. Contraception. 55:1997;131-137.
16. Sulak P., Lippman J., Siu C., Massare J., Godwin A. Clinical comparison of triphasic norgestimate/35 μ ethinyl estradiol and monophasic norethindrone acetate/20 μg ethinyl estradiol. Contraception. 59:1999;161-166.
17. Chavez A., DelConte A. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 μg/20 μg versus triphasic norethindrone/estradiol 500-750-1000 μg/35 μg A multicenter, randomized, open-label study . Eur J Contracep Reprod Health Care. 4:1999;75-83.
18. Trends in oral contraceptive prescribing: an update. Contracept Rep 1999;12-14.
19. Cutler S.J., Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis. 8:1958;699-712.
20. Higgins J.E., Wilkens L.R. Statistical comparison of Pearl rates. Am J Obstet Gynecol. 151:1985;656-659.
21. Koch G.G., Atkinson S.S., Stokes M.E. Poisson Regression. Kotz S., Johnson N.L. Encyclopedia of Statistical Sciences, Volume 7. 7:1986;32-41 John Wiley, New York.
22. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Statist Assn. 47:1952;583-621.
23. Lammers P., op ten Berg M. Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol. Acta Obstet Gynecol Scand. 70:1991;497-500.
24. Archer D.F., Malheux R., DelConte A., O'Brien F.B. A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. Contraception. 55:1997;139-144.
25. An open-label multicenter noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. Am J Obstet Gynecol. 179:1998;S2-S8.
26. Abma J.C., Chandra A., Mosher W.D., Peterson L., Piccinino L. Fertility, family planning, and women's health New data from the 1995 National Survey of Family Growth. National Center for Health Statistics . Vital Health Stat. 23:1997;51.